Involved-Field Irradiation in Definitive Chemoradiotherapy for T4 Squamous Cell Carcinoma of the Esophagus | Zendy

M. Li | Zendy; Fanghui Zhao | Zendy; X. Zhang | Zendy; Fang Shi | Zendy; Hui Zhu | Zendy; A. Han | Zendy; Yulin Zhang | Zendy; Li Kong | Zendy; Jianxing Yu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Involved-Field Irradiation in Definitive Chemoradiotherapy for T4 Squamous Cell Carcinoma of the Esophagus

Author(s) -

M. Li,

Fanghui Zhao,

X. Zhang,

Fang Shi,

Hui Zhu,

A. Han,

Yulin Zhang,

Li Kong,

Jianxing Yu

Publication year - 2016

Publication title -

current oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.053

H-Index - 51

eISSN - 1718-7729

pISSN - 1198-0052

DOI - 10.3747/co.23.2846

Subject(s) - medicine , esophagus , chemoradiotherapy , radiation therapy , esophagitis , gastroenterology , esophageal cancer , stage (stratigraphy) , oncology , cancer , cohort , carcinoma , surgery , disease , reflux , biology , paleontology

Definitive concurrent chemoradiotherapy (ccrt) is currently a therapeutic option for locally advanced esophageal cancer. However, clinical practice differs with respect to the target volume for irradiation. The purpose of the present study was to analyze failure patterns and survival, and to determine the feasibility of using involved-field irradiation (ifi) with concurrent chemotherapy for T4 squamous cell carcinoma (scc) of the esophagus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research